In a phase 1 study of the oral p53 reactivator rezatapopt in heavily pretreated patients with TP53 Y220C–mutated solid tumors, the most common adverse events were nausea and vomiting, and the overall response was 20%. Full PYNNACLE study results: https://t.co/LBqROGlouc
Science behind the Study: Restoring Function to a Variant of p53 in Solid Tumors https://t.co/5Ox6Kuax6Q
Significant progress for patients with sarcoma at #ASCO25 with positive results from 3 phase III trials. Pimicotinib for TGCT, anlotinib for STS and catequentinib for LMS. All are TKIs. @CleClinicMD#CleClinicCancer
The 2025 @ClevelandClinic 17th Annual International Symposium on #SBRT & #SRS will be held February 21-23, bringing together world leaders in brain, spine and body-targeted stereotactic radiation modalities and techniques. Register here: https://t.co/X043vFrA2L
Listen to @CleClinicMD, Cancer Advances’ 200th episode featuring Dr. Greg Videtic! Dr. Videtic joins @ShepardDale to discuss neuroprotection in small-cell lung cancer patients and key findings from the NRG CC003 trial. https://t.co/HixZ8kz8B2 #CleClinicCancer#200thepisode
Use of pembrolizumab with radiation therapy and surgery improved outcomes for certain patients with soft tissue sarcoma. Read the full story, plus expert perspective from @ShepardDale@CleClinicMD@Merck#Keytruda#immunotherapy
https://t.co/icQboRhiaJ
On the @CleClinicMD, Cancer Advances podcast this week, Dr. Lily Wang joins @ShepardDale to discuss how targeting VISTA & LRIG1 interactions could revolutionize treatment for resistant tumors. #Immunotherapy#CleClinicCancer https://t.co/4CWhs7pcg8
@LukasDelasos joins @ShepardDale on Cancer Advances #podcast this week to discuss exciting advancements in #SCLC treatment. Listen as they discuss ongoing research & clinical trials to find better ways to manage this aggressive cancer. #CleClinicCancer https://t.co/g0WurPbWm1
Honored to represent @bikeVeloSano and throw a first pitch last night at the @CleGuardians game! It was a great experience! VeloSano supports cancer research @ClevelandClinic. Visit https://t.co/epSV8oygoY to learn more.
Dr. Khorana discusses research exploring microbiome alterations in individuals with young or early-onset colorectal cancer @aakonc@ShepardDale#microbiome
https://t.co/gGcWXnM3BC via @clevelandclinic
Check out our new Cancer Advances podcast with @aakonc, as he talks about his research on how the changes in the microbiome are shown to be linked to the development and progression of #colorectalcancer in younger patients. #CleClinicCancer https://t.co/hFCk7VAu5s
Listen to this week's episode of Cancer Advances with Alison Ibsen, Senior Director for Cancer Programming, who discusses with @ShepardDale the importance of collaboration across departments to create effective care pathways. #CleClinicCancer https://t.co/qMq7BOK8eL